Su L, Wang D, Purwin TJ, Ran S, et al. Selective USP7 inhibition synergizes with MEK1/2 inhibitor to enhance immune responses and potentiate anti-PD-1 therapy in NRAS mutant melanoma. J Invest Dermatol 2025 Apr 7:S0022-202X(25)00384.
PMID: 40204067